This workshop, organized by the ISMRM MR of Cancer Working Group, will focus on the development and application of novel MRI/MRS acquisition and analysis technologies for cancer. At this bi-annual workshop, we will address and highlight strategies for successfully traversing the translational pipeline. Topics will include development and validation of new cancer imaging methods, analysis tools and probes, preclinical application, first-in-human studies, image-guided therapies, clinical trial evaluation, quality assurance and benchmarking, and clinical best practices.

The program will feature invited scientific presentations from a diverse group of experts in technical innovation and clinical practice (physicians and SMRT members), in addition to proffered papers and poster sessions. The Bill Negendank Young Investigator Awards, for which students, trainees, and post-doctoral fellows are eligible, will also be awarded based on the quality of the presented work.

Target Audience: The workshop is designed for basic scientists, physicians, regulators, technologists, students, trainees, and postdoctoral fellows with an interest in cancer MRI/MRS.